RHJA
VMD icon

Rice Hall James & Associates’s Viemed Healthcare VMD Stock Holding History

Rice Hall James & Associates’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.12M Hold
230,382
– – 0.12% 159
2025
Q4 		$1.71M Buy
230,382
+30,981
+16% +$212K 0.09% 172
2025
Q3 		$1.35M Sell
199,401
-39,672
-17% -$269K 0.07% 188
2025
Q2 		$1.65M Sell
239,073
-21,126
-8% -$143K 0.09% 176
2025
Q1 		$1.89M Buy
260,199
+415
+0.2% +$3.26K 0.11% 164
2024
Q4 		$2.08M Buy
+259,784
New +$2.25M 0.11% 173
2022
Q1 		– Sell
-376,602
Closed -$1.97M – 320
2021
Q4 		$1.97M Sell
376,602
-57,803
-13% -$323K 0.07% 213
2021
Q3 		$2.41M Sell
434,405
-94,494
-18% -$615K 0.09% 176
2021
Q2 		$3.78M Buy
528,899
+79,065
+18% +$685K 0.13% 116
2021
Q1 		$4.55M Buy
+449,834
New +$4.23M 0.15% 118

Other funds holding VMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Rice Hall James & Associates's VMD Position: Q1 2026 in Review

Rice Hall James & Associates held its Viemed Healthcare (VMD) position steady in Q1 2026 at 230,382 shares worth $2.12M. The position accounts for 0.12% of the portfolio, ranked #159.

Rice Hall James & Associates first reported a position in VMD in Q1 2021 and has held it in 10 quarters since. The position peaked at $4.55M in Q1 2021. 149 funds tracked by Wall St. Rank hold VMD as of Q1 2026.

  • Rice Hall James & Associates held 230,382 shares of Viemed Healthcare worth $2.12M as of Q1 2026.
  • Rice Hall James & Associates left its Viemed Healthcare share count unchanged in Q1 2026.
  • Viemed Healthcare made up 0.12% of Rice Hall James & Associates's portfolio in Q1 2026, its #159 holding.
  • Rice Hall James & Associates first reported a position in Viemed Healthcare in Q1 2021 and has held it in 10 quarters since.
  • Rice Hall James & Associates's Viemed Healthcare position peaked at $4.55M in Q1 2021.
  • 149 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2026.

Based on Rice Hall James & Associates's 13F filing for Q1 2026, filed 15 May 2026.